Generic pharmaceuticals

/Tag: Generic pharmaceuticals

Intermountain to fight pharmaceutical monopolies

As Dan Liljenquist watched former Turing Pharmaceuticals CEO Martin Shkreli raise a rarely-heard-of-drug more than 550%, he had the same thought as nearly everyone else in America: Is this really happening? But unlike most Americans, Liljenquist happens to be in a position to do something about it. The former Utah state senator and the vice president of

The story of Alvogen and the founding of a pharma empire

The pharmaceutical sector in the United States is undergoing a seismic shift. In recent years, generic pharmaceuticals, which are equivalent to branded drugs in everything apart from their price and name, have been expanding their share of the market at a rapid pace. At around 50 to 70 percent cheaper than their branded equivalents, more

Curing America’s Expensive Drugs

The United States spent $457 billion on prescription drugs in 2015, nearly 17 percent of total healthcare spending. The Department of Health and Human Services estimates this figure will grow to $535 billion by 2018. Bringing a new drug to the market is notoriously expensive due to research and development, time opportunity costs, and jumping through hoops for FDA